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Hemoglobin Grange-Blanche [f127(B9) Ala~Val] is a new variant found in a Portuguese family. The carriers 
present moderate erythrocytosis. Upon isoelectric focusing, Hb Grange-Blanche was slightly more cathodic 
than Hb A. flGrange-ala,che ain migrated like the cy chain when submitted to electrophoresis in the presence 
of urea-Triton X-100. The precentage ofHb Grange-Blanche was about 50% in the heterozygous state. Oxy- 
gen affinity was increased (Ps0 = 22 mmHg), but heme-heme interaction was normal. An abnormal tryptic 
peptide (fiT3) was isolated using HPLC. Its composition allowed us to deduce unambiguously the amino 
acid change. The latter is the third mutation found in position 27 of the fl-chain. Because of its normal 
expression and its elevated affinity for oxygen, Hb Grange-Blanche contrasts with Hb Knossos [f127(B9) 
Ala ~ Ser], a fl-thalassemic variant with low affinity. 
Globin chain variant; Oxygen affinity; Peptide mapping 
1. INTRODUCTION 
Over 70 variants of the human hemoglobin fl- 
chain display an increased affinity for oxygen [1], 
the most common functional alteration caused by 
abnormal hemoglobins. Such variants are usually 
recognized because of erythrocytosis. Six muta- 
tions involving the B helix (position 19-34) and 
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yielding an increased affinity have been described 
[1]. We report herein on Hb Grange-Blanche 
[ff27(B9) Ala~Val],  a new variant in this region 
with an elevation of oxygen affinity and a normal 
heme-heme interaction. 
2. CASE REPORT 
The propositus was born in Silves, Portugal, in 
1954. She had no medical record until last year 
when she started complaining of abdominal pains. 
Echography showed no gall-stone, but revealed a
spleen enlargement. The cause of the latter, 
however, turned out to be apparently unrelated to 
the abnormal hemoglobin. The red cell indices in- 
dicated moderate rythrocytosis (RBC, 5.16 T. 1-1, 
Hb, 155 g.l-1; PCV, 0.48 1.1-1). The reticulocyte 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 59 
Volume 223, number 1 FEBS LETTERS October 1987 
Fig.l. Electrophoretic analyses. C, control; P, 
propositus; NB, newborn. (a) Hemoglobin IEF on 
polyacrylamide g l [2]. (b) Urea-Triton PAGE of globin 
chains [3]. 
count was 35 x l09 1-1 and Heinz bodies were ab- 
sent. The propositus has two daughters, who were 
born in 1972 and 1974. The eldest is hematological- 
ly normal. The youngest has a comparable picture 
(RBC, 5.21 T. I -1;  Hb, 15 g.l-1; PCV, 0.45 1.1-~), 
but no splenomegaly. In all three persons the 
percentages of Hb A2 and Hb F found were in nor- 
mal range. 
3. MATERIALS AND METHODS 
Hemoglobin screening techniques included IEF 
of total hemoglobins on polyacrylamide gel [2] or 
agarose gel (Sebia, Issy-les-Moulineaux, France), 
and urea-Triton-PAGE of globin chains [3]. The 
assay of Hb A2 relied on chromatofocusing [4]and 
that of Hb F on the alkali-resistance procedure [5]. 
An oxygen equilibrium curve was obtained from 
whole blood in a Hemoscan differential spec- 
trophotometer. Hemoglobin stability was 
evaluated by the isopropanol procedure [6]. 
2,3-Diphosphoglycerate (2,3-DPG) was assayed 
according to Rose and Liebowitz [7]. Structural 
analysis of the variant was carried out as has been 
detailed or referred to elsewhere [8]. Briefly, 
globin chains were separated on CM-52 cellulose. 
Following aminoethylation and tryptic digestion, 
the peptides were resolved using HPLC.  All pep- 
tides were submitted to acid hydrolysis and their 
amino acid composition determined. 
4. RESULTS 
IEF on polyacrylamide gel revealed a 
hemoglobin variant 1 mm from Hb A on its 
cathodic side (fig.l). The abnormal ~?-chain 
migrated as the oy chain upon urea-Triton-PAGE 
(fig. 1). The variant, hereafter called Hb Grange- 
Blanche, accounted for 50°7o of the sum (Hb A + 
Hb Grange-Blanche) (table 1). 
The oxygen equilibrium curve was shifted left- 
ward (fig.2). Pso was slightly decreased (table 1): 
For low Po2 values, the Hill plots bent as in con- 
trols, failing to display a genuinely biphasic 
character. The red cell 2,3-DPG was also normal. 
Finally, normal stability was found. 
Table l 
Structural and functional data concerning Hb Grange-Blanche 
Hb Grange- ~B Ps0 n 2,3-DPG 
Blanche (%) (%) (mmHg) ~mol/g Hb) 
Mother 50.6 54 22 2.87 15.2 
Daughter 1 0 0 25 2.72 12.4 
Daughter 2 49.3 n.d. 22 2.98 14.3 
Day control 26.7 2.91 11.8 
Controls (n -- 15) 27.2 _+ 1.57 2.69 + 0.11 12.83 _+ 1.90 
The percentage of Hb Grange-Blanche with respect to the sum (Hb A + Hb Grange- 
Blanche) was determined by scanning the isoelectric focusing agarose gels (not shown) 
at 525 nm. The percentage oft5 ~B chain with respect to total H-chains was determined 
by scanning urea-Triton X-100 gels at 570 nm; n, slope of the Hill plots for 
30 mmHg < Po2 < 50 mmHg. n.d., not determined 
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Fig.2. Oxygen equilibrium curves. C, control; P, 
propositus. Inset: Hill plots. 
#A and ~B chains coeluted upon CM-52 ion- 
exchange chromatography. Following amino- 
ethylation and tryptic digestion of mixed/?-chains, 
HPLC analysis of the peptides revealed an addi- 
tional peak (fig.3). Its amino acid composition was 
that of a modified fiT3 peptide: Asx, 2.10 (2); Glx, 
1.95 (2); Gly, 2.92 (3); Ala, 0 (1); Val, 4.02 (3); 
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Fig.3. HPLC profile of the tryptic digest of mixed, 
aminoethylated normal (6 'A) and abnormal ~x) chains. 
Leu, 1.14 (1); Arg, detected (1). There was no 
other ectopic peptide; the amino acid composition 
of all regular peptides was determined and found 
to be normal. Taken together, the present data are 
consistent with the Ala--,Val substitution i posi- 
tion 27, a previously undescribed mutation as far 
as we are aware. 
5. DISCUSSION 
After Hb Volga [f127(B9) Ala~Asp] [9] and Hb 
Knossos [f127(B9) Ala-oSer] [10], Hb Grange- 
Blanche [6'27(B9) Ala--*Val] is the third abnormal 
hemoglobin found with an amino acid substitution 
in position 27 of the g-chain. The electrophoretic 
behaviour of this globin variant and its 50% level 
in the heterozygous state should allow rapid 
presumptive diagnosis in future cases. 
Hb Grange-Blanche contrasts with Hb Knossos 
in several respects. (i) Although both hemoglobins 
derive from electrically neutral mutations, Hb 
Grange-Blanche is readily detected using isoelectric 
focusing, while Hb Knossos is not; the slight in- 
crease of pI concerning the former must reflect a 
conformational change. (ii) Upon urea-Triton- 
PAGE, the fl6B chain, resulting from a non-polar 
to a more non-polar substitution, has a slower 
migration toward the cathode than the flA chain 
whereas the flr~ossos chain, resulting from non- 
polar to polar amino acid substitution, has a faster 
migration. (iii) Hb Grange-Blanche has an in- 
creased oxygen affinity while Hb Knossos has a 
reduced affinity• (iv) The 50% level of Hb Grange- 
Blanche denotes a normal expression of the mutant 
~'-chain. This contrasts with the depressed syn- 
thesis off l  ~°s~°s chain, which is responsible for its 
thalassemic character (see [8,11 ], for more details)• 
In the B helix, residue d27 occupies an internal 
position. It does not participate in the ot~l or in 
the t~u~2 contacts, nor is it involved in the heme 
pocket [12]. Although all peptides of the HPLC 
profile are derived from an equimolar mixture of 
the ~,A and ~B chains (unseparated by CM-52 
chromatography), their normal amino acid com- 
position makes it unlikely that the reduced Pso of 
Hb Grange-Blanche would be accounted for by a 
second mutation• Further studies will be necessary 
to establish why the f127(B9) Ala--,Val substitution 
yields increased affinity for oxygen• 
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